Oncology & Cancer

Oxford University researchers have unveiled a new blood test, powered by machine learning, that shows promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect.

Preclinical research findings from the University of North Carolina Lineberger Comprehensive Cancer Center have identified a cocktail of three different drugs that can be used to generate more robust immune system CAR-Ts (chimeric antigen receptor-T cells) to fight cancer. This finding may have a significant impact on improving the production of CAR-T cells for clinical use.

With cancer still rising in the U.S. Latino population, leaders at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and national cancer experts have published an online book with innovative recommendations to reduce Latino cancer.

The development of new drugs is critical in treating cancer—if people have access to them. A team co-led by Penn State researchers identified cancer drugs launched between 1990 and 2022 and found that counties with higher gross national income per capita typically had more launches and shorter launch delays.

A prototype of a new oral cancer diagnosis device, developed by the University of Liverpool, has demonstrated promising results during preliminary tests on histopathology specimens.

Scientists at Children’s Medical Research Institute (CMRI) have solved a big mystery in cancer research—why cells die in different ways following radiotherapy. This surprising finding opens up new opportunities to improve treatment and increase cure rates.

A population-based study indicates that among children with cancer, those with obesity at the time of diagnosis may face an elevated risk of dying. The findings are published online in Cancer.

For women with newly diagnosed invasive breast cancer (BC), weight gain is associated with an increased risk for heart failure, according to a research letter published online Jan. 9 in JAMA Oncology.

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer.

Cervical cancer remains a major health threat for women globally, with the highest incidence in developing nations. Despite the availability of preventive measures, challenges such as limited health care resources and inadequate screening programs continue to undermine global efforts to eliminate the disease.